Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin

Annals of Pharmacotherapy

Volumn 44, Issue 10, 2010, Pages 1665-1668

  Wood, G Christopher ^a   Underwood, Elizabeth L ^a   Croce, Martin A ^a   Swanson, Joseph M ^a   Fabian, Timothy C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Aerosolization; Colistin; Doxycycline; Stenotrophomonas maltophilia; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; CEFEPIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MINOCYCLINE; TIMENTIN; VANCOMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANASTOMOSIS; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; BODY TEMPERATURE; BRAIN HEMORRHAGE; CASE REPORT; COLONY FORMING UNIT; COMPUTER ASSISTED TOMOGRAPHY; DISK DIFFUSION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EMERGENCY HEALTH SERVICE; ERADICATION THERAPY; FEVER; FOLLOW UP; GLASGOW COMA SCALE; HEAD INJURY; HOSPITALIZATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG LAVAGE; MALE; NONHUMAN; NURSING HOME; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECURRENT INFECTION; SKULL FRACTURE; STENOTROPHOMONAS MALTOPHILIA; SUBARACHNOID HEMORRHAGE; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; COLISTIN; DOXYCYCLINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; STENOTROPHOMONAS MALTOPHILIA; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77957671024     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P217     Document Type: Article

References (16)

1. Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 2001;32(suppl 2):S104-13.
2. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009;9:312-23.
3. Hess MM, Boucher BA, Laizure SC, et al. Trimethoprim-sulfamethoxazole pharmacokinetics in trauma patients. Pharmacotherapy 1993;13:602-6.
4. Wood GC, Mueller EW, Croce MA, Boucher BA, Hanes SD, Fabian TC. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surg Infect (Larchmt) 2005;6:203-13.
5. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007;28:825-31.
6. Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002;35:228-35.
7. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis 2007;26:13-29.
8. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
9. Irifune K, Ishida T, Shimoguchi K, et al. Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype. J Clin Microbiol 1994;32:2856-7.
10. Wood GC, Hanes SD, Boucher BA, Croce MA, Fabian TC. Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Intensive Care Med 2003;29:2072-6.
11. Holloway KP, Rouphael NG, Wells JB, King MD, Blumberg HM. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit. Ann Pharmacother 2006;40:1939-45. DOI 10.1345/aph.1H353
12. Linden PK, Paterson DL. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 2006;43(suppl 2):S89-94.
13. Wood GC, Swanson JM. Aerosolized antibiotics for the prevention and treatment of hospital-acquired pneumonia. Drugs 2007;67:903-14.
14. Food and Drug Administration. Public Health Advisory: colistimethate (marketed as Coly-Mycin M and generic products). Released 6/28/2007. www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/UCM051283 (accessed 2010 June 28).
15. Croce MA, Fabian TC, Waddle-Smith L, et al. Use of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227:743-55.
16. Croce MA, Fabian TC, Mueller EW, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004;56:931-6.